Hiom, Kevin

Professor, Head of Division of Cellular Medicine

Calculated based on number of publications stored in Pure and citations from Scopus
1992 …2023

Research activity per year

Personal profile


Professor Kevin Hiom is the Pat McPherson Chair in Cancer Biology. Kevin did his undergraduate degree at the University of Liverpool and undertook his PhD at the MRC National institute for Medical Research where he studies the responses of bacterial cells to DNA damage caused by ultraviolet light. In 1991 Kevin moved to the Imperial Cancer Research Fund Clare Hall Lab’s to work with Dr Stephen West FRS on the biochemistry of genetic recombination and then in 1995 moved to the National Institutes of health, Bethesda Maryland USA to work on V(D)J recombination with Dr Martin Gellert. In 1998 Kevin started his own group at the MRC Laboratory of Molecular Biology in Cambridge, working on the role of DNA repair in preventing human disease. In 2009 Kevin relocated to the School of Medicine at the University of Dundee where he is now the Head of the Division of Cellular Medicine. During his career Kevin has been awarded a number of prizes including the NIH Fellows Award for Research Excellence (1998), Pfizer Academic Award for work on the mechanism of V(D)J recombination (1999), Fanconi Anemia Research Fund Discovery Award (2005) for the identification of the FANCJ gene and the European Association for Cancer Research Cancer Researcher Award Lecture (2009).


Kevin Hiom’s group researches the mechanisms by which cells deal with damage to their genetic material DNA and how, when this goes wrong, it can lead to human disease. In particular Kevin’s group have an interest in the repair of DNA breaks. During his post-doctoral career Kevin showed how DNA breaks generated during the development of the immune system could result in the formation of cancer causing translocations in which DNA from two different chromosomes become fused. Since 1998 Kevin’s research has focused on the function of the important cancer causing gene BRCA1 which is defective in patients with a predisposition to early onset breast and ovarian cancer. His lab also identified a protein, related to BRCA1, was the cause of the human inherited blood disease Fanconi anaemia. In recent times the Hiom lab is focused on the role of RNA metabolism in the repair of DNA damage and how defects in this process lead to cancers in children and also to neurodegenerative diseases.


Professor Hiom is an active participant in undergraduate and postgraduate teaching. He contributes lectures to module BS42007 (Cancer Biology), module BS42027 (Cancer Pharmacology and treatment) and BS32029 (Cell proliferation and survival mechanisms underlying disease) in Biological /Biomedical sciences. He also lectures on DNA repair in the BMSc module in Cancer and several lectures for the MRes Cancer Biology taught post-graduate masters course. His specialist teaching is in the mechanisms of genome stability and its role in disease.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where Kevin Hiom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or